[go: up one dir, main page]

UA115684C2 - Фармацевтична композиція для перорального застосування, що містить декскетопрофен та трамадол - Google Patents

Фармацевтична композиція для перорального застосування, що містить декскетопрофен та трамадол

Info

Publication number
UA115684C2
UA115684C2 UAA201508027A UAA201508027A UA115684C2 UA 115684 C2 UA115684 C2 UA 115684C2 UA A201508027 A UAA201508027 A UA A201508027A UA A201508027 A UAA201508027 A UA A201508027A UA 115684 C2 UA115684 C2 UA 115684C2
Authority
UA
Ukraine
Prior art keywords
group
tramadol
pharmaceutical
dextetroprophene
oral application
Prior art date
Application number
UAA201508027A
Other languages
English (en)
Inventor
Райнгард Шміц
Тобіас Коль
Original Assignee
Лабораторіос Менаріні Са
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47953547&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA115684(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Лабораторіос Менаріні Са filed Critical Лабораторіос Менаріні Са
Publication of UA115684C2 publication Critical patent/UA115684C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Винахід стосується фармацевтичної композиції як твердої лікарської форми для перорального застосування, яка містить: і) комбінацію двох фармакологічно активних компонентів, солі декскетопрофену з органічною основою та солі трамадолу з органічною кислотою, в якій: - органічну основу вибрано з групи, яка складається з трометамолу, L-лізину, L-аргініну; - органічну кислоту вибрано з групи, яка складається з соляної, бромистоводневої кислоти; іі) мікрокристалічна целюлоза є наповнювачем; ііі) зв'язувальний агент вибрано з групи, яка складається з кукурудзяного крохмалю, попередньо желатинізованого кукурудзяного крохмалю та гіпромелози або їх сумішей; iv) фармацевтично прийнятний наповнювач, і в якій всі компоненти композиції знаходяться у фізичному контакті один з одним.
UAA201508027A 2013-02-14 2014-02-06 Фармацевтична композиція для перорального застосування, що містить декскетопрофен та трамадол UA115684C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000210A ITMI20130210A1 (it) 2013-02-14 2013-02-14 Composizioni farmaceutiche contenenti dexketoprofene e tramadolo
PCT/EP2014/052342 WO2014124862A1 (en) 2013-02-14 2014-02-06 Pharmaceutical compositions containing dexketoprofen and tramadol

Publications (1)

Publication Number Publication Date
UA115684C2 true UA115684C2 (uk) 2017-12-11

Family

ID=47953547

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201508027A UA115684C2 (uk) 2013-02-14 2014-02-06 Фармацевтична композиція для перорального застосування, що містить декскетопрофен та трамадол

Country Status (45)

Country Link
US (1) US9949940B2 (uk)
EP (1) EP2956129B1 (uk)
JP (1) JP6297068B2 (uk)
KR (1) KR102262408B1 (uk)
CN (1) CN105007907B (uk)
AP (1) AP2015008616A0 (uk)
AR (1) AR094783A1 (uk)
AU (1) AU2014218110B2 (uk)
BR (1) BR112015018952B1 (uk)
CA (1) CA2900979C (uk)
CL (1) CL2015002251A1 (uk)
CR (1) CR20150411A (uk)
CU (1) CU24310B1 (uk)
CY (1) CY1120301T1 (uk)
DK (1) DK2956129T3 (uk)
EA (1) EA029709B1 (uk)
EC (1) ECSP15034660A (uk)
ES (1) ES2672986T3 (uk)
GE (1) GEP201706649B (uk)
HR (1) HRP20180974T1 (uk)
HU (1) HUE038417T2 (uk)
IL (1) IL240514B (uk)
IT (1) ITMI20130210A1 (uk)
LT (1) LT2956129T (uk)
MA (1) MA38335B1 (uk)
MX (1) MX353897B (uk)
MY (1) MY173102A (uk)
NI (1) NI201500105A (uk)
NO (1) NO2956129T3 (uk)
NZ (1) NZ710967A (uk)
PE (1) PE20151430A1 (uk)
PH (1) PH12015501766B1 (uk)
PL (1) PL2956129T3 (uk)
PT (1) PT2956129T (uk)
RS (1) RS57271B1 (uk)
SA (1) SA515360877B1 (uk)
SG (1) SG11201506291UA (uk)
SI (1) SI2956129T1 (uk)
SM (1) SMT201800356T1 (uk)
TN (1) TN2015000345A1 (uk)
TR (1) TR201810114T4 (uk)
TW (1) TWI642430B (uk)
UA (1) UA115684C2 (uk)
UY (1) UY35324A (uk)
WO (1) WO2014124862A1 (uk)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022023211A1 (en) 2020-07-31 2022-02-03 Krka, D.D., Novo Mesto Formulation containing dexketoprofen and tramadol and method for making the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661723B2 (en) 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5516803A (en) * 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5968551A (en) 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
ES2058024B1 (es) 1992-11-10 1995-05-01 Menarini Lab Nuevo derivado arilpropionico, procedimiento de fabricacion del mismo y su utilizacion como analgesico.
DE19530575A1 (de) 1995-08-19 1997-02-20 Gruenenthal Gmbh Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
CA2322315C (en) * 1998-03-06 2008-09-16 Eurand International S.P.A. Fast disintegrating tablets
EP1739072A1 (en) 2005-06-15 2007-01-03 Laboratorios Menarini S.A. Polymorphic forms of dexketoprofen trometamol, preparation and pharmaceutical compositions thereof
AU2006269225B2 (en) 2005-07-07 2011-10-06 Farnam Companies, Inc. Sustained release pharmaceutical compositions for highly water soluble drugs
ITMI20060983A1 (it) * 2006-05-18 2007-11-19 Formevet S P A Composizioni farmaceutiche veterinarie per il trattamento del dolore e dell'inifiamazione
BRPI0700133A (pt) * 2007-01-29 2008-09-16 Incrementha P D & I Pesquisa D composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
WO2008150324A1 (en) * 2007-03-26 2008-12-11 Theraquest Biosciences, Inc. Subanalgesic doses of drug combinations
EP2177215A1 (en) * 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs
ES2356762B1 (es) * 2009-09-04 2011-11-24 Farmalider S.A. Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma.

Also Published As

Publication number Publication date
MX353897B (es) 2018-02-01
CU20150081A7 (es) 2016-01-29
EP2956129A1 (en) 2015-12-23
CU24310B1 (es) 2018-01-10
PL2956129T3 (pl) 2018-09-28
SA515360877B1 (ar) 2018-04-29
TR201810114T4 (tr) 2018-08-27
JP2016507577A (ja) 2016-03-10
US9949940B2 (en) 2018-04-24
PT2956129T (pt) 2018-06-14
PH12015501766B1 (en) 2021-09-08
PE20151430A1 (es) 2015-10-13
AU2014218110A1 (en) 2015-08-27
SI2956129T1 (en) 2018-06-29
TW201442703A (zh) 2014-11-16
EP2956129B1 (en) 2018-04-18
WO2014124862A1 (en) 2014-08-21
KR102262408B1 (ko) 2021-06-08
HK1216840A1 (zh) 2016-12-09
CY1120301T1 (el) 2019-07-10
TN2015000345A1 (en) 2017-01-03
NO2956129T3 (uk) 2018-09-15
IL240514A0 (en) 2015-10-29
SMT201800356T1 (it) 2018-09-13
TWI642430B (zh) 2018-12-01
HRP20180974T1 (hr) 2018-08-10
MA38335A1 (fr) 2016-12-30
MA38335B1 (fr) 2017-12-29
GEP201706649B (en) 2017-03-27
BR112015018952B1 (pt) 2022-09-13
MX2015010431A (es) 2015-10-05
ECSP15034660A (es) 2019-03-29
RS57271B1 (sr) 2018-08-31
ES2672986T3 (es) 2018-06-19
KR20150115803A (ko) 2015-10-14
AR094783A1 (es) 2015-08-26
EA029709B1 (ru) 2018-05-31
CA2900979C (en) 2021-04-13
AU2014218110B2 (en) 2018-08-09
EA201591319A1 (ru) 2016-01-29
CA2900979A1 (en) 2014-08-21
CL2015002251A1 (es) 2016-02-05
NI201500105A (es) 2015-09-10
NZ710967A (en) 2019-08-30
MY173102A (en) 2019-12-26
AP2015008616A0 (en) 2015-07-31
BR112015018952A2 (pt) 2017-07-18
CN105007907A (zh) 2015-10-28
UY35324A (es) 2014-08-29
DK2956129T3 (en) 2018-06-18
CR20150411A (es) 2015-12-07
CN105007907B (zh) 2017-06-09
PH12015501766A1 (en) 2015-11-09
SG11201506291UA (en) 2015-09-29
US20150374650A1 (en) 2015-12-31
LT2956129T (lt) 2018-06-11
ITMI20130210A1 (it) 2014-08-15
JP6297068B2 (ja) 2018-03-20
IL240514B (en) 2019-10-31
HUE038417T2 (hu) 2018-10-29

Similar Documents

Publication Publication Date Title
MX2016006053A (es) Compuestos selectivos de peptido yy (pyy) y usos de los mismos.
EA201490014A1 (ru) Модифицированное высвобождение 4-метил-3-[[4-(3-пиридинил)-2-пиримидинил]амино]-n-[5-(4-метил-1h-имидазол-1-ил)-3-(трифторметил)фенил]бензамида, солюбилизированного с использованием органических кислот
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
PH12016501310B1 (en) Pharmaceutical compositions comprising azd9291
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
UA94942C2 (uk) Фармацевтичні композиції з інгібіторами dpp iv
UA105229C2 (uk) Фармацевтичний склад
UA116334C2 (uk) Тверді форми дозування бендамустину
UA109421C2 (uk) Фармацевтична композиція, яка містить ліганди сигма-рецептора
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
WO2014006636A3 (en) Stable compositions of fesoterodine
UA115684C2 (uk) Фармацевтична композиція для перорального застосування, що містить декскетопрофен та трамадол
IN2014DN07898A (uk)
WO2012153347A3 (en) Oral pharmaceutical composition of olanzapine form 1 and sodium starch glycolate
RU2010154205A (ru) Твердая лекарственная форма препаратов мемантина и его солей
JP2012072106A5 (uk)
TR201005911A2 (tr) Geliştirilmiş dissolüsyon profiline sahip bir ilaç formülasyonu.
TH110692A (th) สูตรผสมชนิดใหม่,ยาเม็ดซึ่งประกอบรวมด้วยสูตรผสมดังกล่าว,การใช้ของสูตรผสมนั้น และกระบวนการสำหรับการเตรียมสูตรผสมนั้น
TN2013000440A1 (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
UA83889U (uk) Фармацевтична композиція у вигляді таблетки